Highlands Oncology Group — Rogers, Arkansas

Highlands Oncology Group is a clinical research site located in Rogers, Arkansas, United States 72758.

Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.

Highlands Oncology Group has participated in 40 clinical trials with 8 currently active.

Therapeutic areas: Gastric Cancer, Gastric Adenocarcinoma, Breast Cancer.

Sponsors: Elevar Therapeutics, Pfizer, BostonGene.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rogers

Browse all research sites in Arkansas · View every site in Rogers

• St. Mary's Hospital
• Mercy Hospital Northwest Arkansas
• Woodland Research Northwest
• Highlands Oncology Group-Rogers
• Northwest Arkansas Clinical Trials Center
• Highlands Oncology Group, PA
• Northwest Arkansas Clinical Trials Center PLLC
• Clinical Site
• Sage Investigational Site
• Research Site
• WRN

Sponsor Feasibility Report

Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Highlands Oncology Group?

Highlands Oncology Group has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Highlands Oncology Group conducted?

Highlands Oncology Group has 40 clinical trials on record, with 8 currently active. Their work covers Gastric Cancer, Gastric Adenocarcinoma, Breast Cancer.

Is Highlands Oncology Group accredited by Crixeo Clinical Trials?

Highlands Oncology Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Highlands Oncology Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.